Consilium Wealth Advisory, LLC Eli Lilly & CO Transaction History

Consilium Wealth Advisory, LLC

$181 Million
Q3 2024

A detailed history of Consilium Wealth Advisory, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Consilium Wealth Advisory, LLC holds 3,982 shares of LLY stock, worth $3.17 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares

3,982

Previous 4,527 12.04%

Holding current value

$3.17 Million

Previous $4.1 Million 13.93%

% of portfolio

1.95%

Previous 2.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$772.14 - $960.02 $420,816 - $523,210	-545 Reduced 12.04%	3,982 $3.53 Million
Q2 2024 Aug 01, 2024	SELL	$724.87 - $909.04 $17,396 - $21,816	-24 Reduced 0.53%	4,527 $4.1 Million
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $5,922 - $7,922	10 Added 0.22%	4,551 $3.54 Million
Q4 2023 Jan 10, 2024	BUY	$525.19 - $619.13 $129,196 - $152,305	246 Added 5.73%	4,541 $2.65 Million
Q3 2023 Oct 10, 2023	BUY	$434.7 - $599.3 $69,986 - $96,487	161 Added 3.89%	4,295 $2.31 Million
Q2 2023 Jul 13, 2023	BUY	$350.74 - $468.98 $109,781 - $146,790	313 Added 8.19%	4,134 $1.94 Million
Q1 2023 Apr 13, 2023	SELL	$310.63 - $364.82 $256,891 - $301,706	-827 Reduced 17.79%	3,821 $1.31 Million
Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $72,027 - $83,926	-224 Reduced 4.6%	4,648 $1.7 Million
Q3 2022 Oct 12, 2022	BUY	$296.48 - $337.87 $15,713 - $17,907	53 Added 1.1%	4,872 $1.58 Million
Q2 2022 Jul 12, 2022	BUY	$278.73 - $327.27 $7,525 - $8,836	27 Added 0.56%	4,819 $1.56 Million
Q1 2022 Apr 18, 2022	SELL	$234.69 - $291.66 $76,039 - $94,497	-324 Reduced 6.33%	4,792 $1.37 Million
Q4 2021 Jan 26, 2022	BUY	$224.85 - $279.04 $1.15 Million - $1.43 Million	5,116 New	5,116 $1.41 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Consilium Wealth Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Consilium Wealth Advisory, LLC with notifications on news.

Account

Consilium Wealth Advisory, LLC Eli Lilly & CO Transaction History